Companies
ABBV
AbbVie Inc.
AbbVie is a research-based biopharmaceutical company that develops and sells medicines across immunology, neuroscience, oncology, and aesthetics therapeutic areas. The company operates as a single global segment focused on discovering, developing, manufacturing, and commercializing innovative therapies for serious diseases. AbbVie's immunology portfolio includes products like Skyrizi (risankizumab), an IL-23 inhibitor for autoimmune conditions across rheumatology, dermatology, and gastroenterology.
$211.32+11.87%1Y
ABBV · daily close · illustrative · 0 catalysts marked
Pipeline
Phase 3Dry Eye Disease
Phase 3Parkinson's Disease (PD)
Phase 3Chronic Lymphocytic Leukemia
Phase 3AMD
Phase 3nAMD
Phase 3Wet Age-related Macular Degeneration
Phase 3wAMD
Phase 3CNV
Phase 3Wet AMD
Phase 3Migraine
Phase 3Menstrual Migraine (MM)
Phase 3Episodic Migraine
Phase 3Chronic Migraine
Phase 3Myelofibrosis (MF)
Phase 2Metastatic Colorectal Cancer
Phase 2Ovarian Cancer
Phase 2Gynecologic Cancers
Phase 2Platinum-Sensitive Ovarian Cancer
Phase 2Fallopian Tube Cancer
Phase 2Primary Peritoneal Cancer (PSOC)
Phase 2Unresectable Metastatic Colorectal Cancer
Phase 2/3Hepatocellular Carcinoma
Phase 3Peritoneal Cancer
Phase 2Epithelial Ovarian Cancer
Phase 2Neoadjuvant
Phase 3Multiple Myeloma
Phase 3Multiple Myeloma
Phase 3Endometriosis
Phase 3Multiple Myeloma
Phase 3Atopic Dermatitis
Phase 3Atopic Dermatitis
Phase 3Endometriosis
Phase 3Multiple Myeloma
Phase 3Ovarian Cancer
Phase 3Peritoneal Cancer
Phase 3Fallopian Tube Cancer
Phase 3Myelofibrosis (MF)
Phase 3Forehead Lines
Phase 3Multiple Myeloma
Phase 3Takayasu Arteritis (TAK)
Phase 3Neovascular Age-Related Macular Degeneration (nAMD)
Phase 3Dry Eye Disease
Phase 3Psoriatic Arthritis (PsA)
Phase 3Ulcerative Colitis (UC)
Phase 3Ulcerative Colitis
Phase 3Crohn's Disease
Phase 3Psoriasis
Phase 3Juvenile Psoriatic Arthritis
Phase 3Psoriatic Arthritis
Phase 3Crohn's Disease (CD)
Phase 3Crohn's Disease
Phase 3Crohn's Disease
Phase 3Crohn's Disease
Phase 3Myelofibrosis (MF)
Phase 3Multiple Myeloma
Phase 3Neovascular Age-Related Macular Degeneration (nAMD)
Phase 3Juvenile Idiopathic Arthritis
Phase 3Atopic Dermatitis
Phase 3Migraine
Phase 3Metastatic Colorectal Cancer
Phase 3Migraine
Phase 3Systemic Lupus Erythematosus
Phase 3Rheumatoid Arthritis
Phase 3Alopecia Areata
Phase 3Juvenile Idiopathic Arthritis
Phase 3Crohn's Disease
Phase 3Ulcerative Colitis
Phase 3Atopic Dermatitis
Phase 3Vitiligo
Phase 3Takayasu Arteritis (TAK)
Phase 3Hidradenitis Suppurativa
Phase 3Ulcerative Colitis (UC)
Phase 3Atopic Dermatitis
Phase 3Atopic Dermatitis
Phase 3Crohn's Disease (CD)
Phase 3Ulcerative Colitis
Phase 2Waldenstrom Macroglobulinemia
Phase 2Lymphoplasmacytic Lymphoma
Phase 3Multiple Myeloma
Phase 3Chronic Lymphocytic Leukemia
Phase 3Acute Myeloid Leukemia
Phase 3Non-Hodgkin's Lymphoma
Phase 3Acute Lymphoblastic Leukemia
Phase 3Cancer
Phase 3Myelodysplastic Syndrome (MDS)
Phase 2Small Lymphocytic Lymphoma (SLL)
Phase 2/3Hypothyroidism
Phase 2/3Hepatocellular Carcinoma
Phase 2Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Phase 2Gastroesophageal Junction Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2/3Non-Small Cell Lung Cancer
Phase 2Urothelial Carcinoma
Phase 2Ovarian Cancer
Phase 2Gynecologic Cancers
Phase 2Platinum-Sensitive Ovarian Cancer
Phase 2Fallopian Tube Cancer
Phase 2Primary Peritoneal Cancer (PSOC)
Phase 2Small Cell Lung Cancer
Phase 2Epithelial Ovarian Cancer
Phase 2Neoadjuvant
Phase 2High Grade Ovarian Cancer
Phase 2/3Non-Small Cell Lung Cancer
Phase 2/3Non-Squamous Non-Small Cell Lung Cancer
Phase 2/3Multiple Myeloma
Phase 2/3Hepatocellular Carcinoma
Phase 2/3Multiple Myeloma
Phase 2/3Multiple Myeloma
Phase 2/3Hypothyroidism
Phase 2/3Hepatocellular Carcinoma
Phase 2/3Non-Small Cell Lung Cancer
Phase 2Urothelial Carcinoma
Phase 2/3Non-Squamous Non-Small Cell Lung Cancer
Phase 2/3Non-Small Cell Lung Cancer
Phase 2/3AMD
Phase 2/3nAMD
Phase 2/3Wet Age-related Macular Degeneration
Phase 2/3wAMD
Phase 2/3CNV
Phase 2/3Neovascular AMD
Phase 2/3Neovascular Age-Related Macular Degeneration (nAMD)
Phase 2/3Choroidal Neovascularization
Phase 2/3Wet AMD
Phase 2Colorectal Cancer
Phase 2/3Non-Small Cell Lung Cancer
Phase 2/3Non-Squamous Non-Small Cell Lung Cancer
Phase 2Metastatic Colorectal Cancer
Phase 2Colorectal Cancer
Phase 2Solid Tumors Harboring MET Amplification
Phase 2/3Non-Small Cell Lung Cancer
Phase 2Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Phase 2Gastroesophageal Junction Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2/3Non-Squamous Non-Small Cell Lung Cancer
Phase 2/3Hepatocellular Carcinoma
Phase 2Idiopathic Pulmonary Fibrosis
Phase 2Immunoglobulin Light Chain (AL) Amyloidosis
Phase 2Unresectable Metastatic Colorectal Cancer
Phase 2Multiple Myeloma
Phase 2Small Cell Lung Cancer
Phase 2Crohn's Disease
Phase 2Autosomal Dominant Polycystic Kidney Disease
Phase 2Ventral Hernia
Phase 2Generalized Anxiety Disorder (GAD)
Phase 2Recurrent Ovarian Cancer
Phase 2Folate Receptor-Alpha Positive
Phase 2Irritable Bowel Syndrome
Phase 2Schizophrenia
Phase 2Small Cell Lung Cancer
Phase 2Metastatic Colorectal Cancer
Phase 2Unresectable Metastatic Colorectal Cancer
Phase 2Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Phase 2Gastroesophageal Junction Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Unresectable Metastatic Colorectal Cancer
Phase 2Urothelial Carcinoma
Phase 2Gynecologic Cancers
Phase 2Platinum-Sensitive Ovarian Cancer
Phase 2Fallopian Tube Cancer
Phase 2Primary Peritoneal Cancer (PSOC)
Phase 2Acute Myeloid Leukemia
Phase 2Blastic Plasmacytoid Dendritic Cell Neoplasm
Phase 2Myeloproliferative Neoplasm
Phase 2Unresectable Metastatic Colorectal Cancer
Phase 2Hepatocellular Carcinoma
Phase 2Metastatic Colorectal Cancer
Phase 2Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Phase 2Gastroesophageal Junction Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Neovascular Age-Related Macular Degeneration (nAMD)
Phase 2Small Cell Lung Cancer
Phase 2Ulcerative Colitis
Phase 2Atopic Dermatitis
Phase 2Hidradenitis Suppurativa
Phase 2Crohn's Disease
Phase 2Psoriatic Arthritis
Phase 2Rheumatoid Arthritis
Phase 2Migraine
Phase 2Recurrent Ovarian Cancer
Phase 2Folate Receptor-Alpha Positive
Phase 2Ovarian Cancer
Phase 2Epithelial Ovarian Cancer
Phase 2Fallopian Tube Cancer
Phase 2Primary Peritoneal Cancer
Phase 2Neoadjuvant
Phase 2High Grade Ovarian Cancer
Phase 2Advanced High-Grade Epithelial Ovarian
Phase 2Primary Peritoneal
Phase 2High Folate Receptor-Alpha Expression
Phase 2Platinum Resistant
Phase 2Chronic Lymphocytic Leukemia (CLL)
Phase 2Gynecologic Cancers
Phase 2Platinum-Sensitive Ovarian Cancer
Phase 2Fallopian Tube Cancer
Phase 2Primary Peritoneal Cancer (PSOC)
Phase 2Metastatic Colorectal Cancer
Phase 2Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
Phase 2Gastroesophageal Junction Adenocarcinoma
Phase 2Esophageal Adenocarcinoma
Phase 2Urothelial Carcinoma
Phase 2Metastatic Colorectal Cancer
Phase 2Recurrent Ovarian Cancer
Phase 2Folate Receptor-Alpha Positive
Phase 2Neovascular Age-Related Macular Degeneration (nAMD)
Phase 2Rheumatoid Arthritis
Phase 2Hepatocellular Carcinoma
Phase 2Non-Small Cell Lung Cancer
Phase 2Multiple Myeloma
Phase 2Neovascular Age-Related Macular Degeneration (nAMD)
Phase 2Diabetic Retinopathy (DR)
Phase 2Center-Involved Diabetic Macular Edema (CI-DME)
Phase 2Crohn's Disease
Catalyst Calendar
No catalyst events on record for yet. Check back after the next daily ingest.